|
|
|
Summary Of: Ancrod
ancrod is not approved or marketed in any country... for investigation of ancrod use in patients suffering from acute... ancrod was marketed in Germany and Austria... currently holds the worldwide rights to ancrod under the brand name Viprinex... Ancrod has a triple mode of action... Ancrod is prepared from the crude... Ancrod may also be found in the venoms of many poisonous snakes... most suitable due to a high concentration of ancrod in its venom... The halflife of ancrod is 3 to 5 hours and the drug is cleared from plasma... The blood viscosity in patients receiving ancrod is progressively reduced by 30 to 40... Ancrod decreases the blood viscosity in affected arteries... ancrod decreases the likelihood of local thrombotic events... ancrod does not directly activate... Ancrod has been shown to be useful for maintaining anticoagulation in the presence of... ancrod given within 6 hours after the onset of acute... placebo was found to be more effective than ancrod and the study was abruptly terminated... in the ancrod group was higher... relatively rapid ancrod infusion with no maintenance dosing will be both effective and safe... Ancrod should not be injected i... Ancrod was not found to be... used during pregnancy as the defibrinogenation mechanism of ancrod might be expected to interfere with the normal implantation of the fertilized egg... appearance of neutralizing antibodies to ancrod with partial or total loss of ancrod activity... effect has never been noticed with ancrod in contrast to heparin... Intravenous ancrod for treatment of acute ischemic stroke... Ancrod for the treatment of acute ischemic brain infarction... The Ancrod Stroke Study Investigators... Intravenous ancrod for acute ischaemic stroke in the European Stroke Treatment with Ancrod Trial... Encyclodia Page On: Ancrod
|
|
 |
